baber/WOPTO huggingface dataset:
Patent AT-E262364-T1 (AT)
Inventor: ATZEN BENT
IPC: A63H33/08
Filed: 2001-01-10
Granted: 2004-04-15
Abstract: A toy building element comprising one or more first beam-like parts (23, 24) with a plane internal face and an external face, and one or more other beam-like parts (21, 22) with a plane internal face and an external face. The beam-like parts are assembled in at least one corner whereby two internal faces are caused to form an angle of less than 180° relative to each other. At least the first beam-like part (23, 24) is/are provided with an opening (7) that extends transversally thereto from the external face to the internal face, and the opening (7) is arranged so far towards the corner that the plane for the face of the plane internal face (4) of the second beam-like part (21, 22) intersects the opening in the plane for the face of the plane internal face (3) of the first beam-like part (23, 24). The plane internal face (4) of the second beam-like part (21, 22) is interrupted at a distance from the opening (7) whereby a clearance is provided around the opening (7) on the internal face of the first beam-like part.
Patent AT-E314860-T1 (AT)
Inventor: EISENBACH-SCHWARTZ MICHAL
IPC: A61K38/00
Filed: 2001-01-22
Granted: 2006-02-15
Abstract: Methods are provided for treating injury to or disease of the central or peripheral nervous system. In one embodiment, treatment is effected by administering activated T cells that recognize an antigen of Cop 1 or a Cop 1-related peptide or polypeptide to promote nerve regeneration or to prevent or inhibit neuronal degeneration within the nervous system. In another embodiment, treatment involves administering Cop 1 or a Cop 1-related peptide or polypeptide to promote nerve regeneration or to prevent or inhibit neuronal degeneration in the nervous system, either the central nervous system or the peripheral nervous system. The activated T cells, which have been activated by the presence of Cop 1 or a Cop 1-related peptide or polypeptide, can be administered alone or in combination with Cop 1 or a Cop 1-related peptide or polypeptide.
Patent AT-E375410-T1 (AT)
Inventor: KLAMM ULLRICH
IPC: C25B15/08
Filed: 2001-02-21
Granted: 2007-10-15
Abstract: This invention relates to an apparatus and a method for the on-site generation of gas of relatively small quantities of a halogen gas, preferably chlorine gas. The apparatus has at least one electrolytic cell having an anolyte section and a catholyte section. At least one of these sections is connected, by fluid conduits, to a fluid heater which heats an electrolyte solution prior to its ingress into the section. Heating also facilitates circulation of the electrolyte solution through the apparatus by means of a thermosyphon effect. The heating element is, in turn, connected to an electrolyte replenishment means. The apparatus includes at least one gas separator which separates gas produced in the electrolytic cell from electrolyte solution. The apparatus lacks a reservoir for the storage of electrolyte solution.
Patent AT-E384360-T1 (AT)
Inventor: FLAKE ROBERT
IPC: H04L25/02
Filed: 2001-03-02
Granted: 2008-02-15
Abstract: Methods for driving a lossy transmission media with an energy wave defined by a an exponential waveform function. The propagation delay and attenuation of the wave is a function of an exponential coefficient, and its propagation velocity is essentially constant and independent of displacement. Utilizing relationships between the propagation velocity, exponential coefficient, attenuation, and transmission line parameters, one may effectively model various transmission media. One may also determine unknown transmission line parameters, waveform exponential coefficients, attenuation, and/or propagation velocities by utilizing those relationships. By modulating the exponential coefficient, information may be encoded onto a waveform.
Patent AT-E405639-T1 (AT)
Inventor: TAKADA MASAYASU
IPC: C12N1/20
Filed: 2001-05-23
Granted: 2008-09-15
Abstract: CGTase having the following enzymatic chemical properties: (1) Function and substrate specificity: funtioning on starch, dextrin, amylopectin, and amylose to produce primarily  gamma  -CD, with the quantities of  beta - and  alpha -CD produced being smaller than the quantity of  gamma  -CD produced; (2) Optimum pH: 10.5-11.0; (3) Optimum temperature: About 60 DEG C; (4) Stable pH: 6-11; and (5) Temperature stability: With a 15 minute-treatment at 50 DEG C, residual activity of not less than 90 percent is exhibited. A method of manufacturing cyclodextrin glucanotransferase in which a microorganism belonging to the species Bacillus clarkii (for example, FERM BP-7156) and having the ability to produce cyclodextrin glucanotransferase is cultured, cyclodextrin glucanotransferase is produced in the cultured product, and the cyclodextrin glucanotransferase that has been produced is collected. A method of manufacturing CD in which CGTase produced by the species Bacillus clarkii is reacted with a solution comprising starch or the like to produce principally  gamma  -cyclodextrin.  gamma  -Cyclodextrin glucanotransferase (CGTase) capable of predominantly producing  gamma -CD, a microorganism having the ability to produce  gamma  -CGTase, and a method of manufacturing  gamma  -CD using  gamma  -CGTase are provided.
Patent AT-E420411-T1 (AT)
Inventor: DRESCHER GEORG
IPC: B26F1/14
Filed: 2001-05-14
Granted: 2009-01-15
Abstract: The device has a stamping punch (10) that interacts with a matrix or counter piece and the plastic material to be stamped is placed between the stamping punch and the counter piece or matrix. The cutting surface of the stamping punch has a cutting angle of less than 90 degrees. The stamping angle is 45 degrees for a V-shaped stamping tool cross-section.
Patent AT-E331502-T1 (AT)
Inventor: JASPROVA DAGMAR
IPC: A61K31/663
Filed: 2001-06-29
Granted: 2006-07-15
Abstract: A tablet, obtainable by direct comprising the active ingredient 4-amino-1-hydroxybutylidene-1,1-bis-phosphonic (alendronic) acid or its pharmaceutically acceptable salts in an amount of 5 to 140 mg, based on the pure acid, a dry binder, a disintegrating agent, a lubricant, the tablet comprising, as the diluent, a combination of at least two diluents except lactose.
Patent AT-E466997-T1 (AT)
Inventor: CAMPBELL CLAYTON
IPC: B31F1/12
Filed: 2001-07-25
Granted: 2010-05-15
Abstract: An adhesive for applying to a creping surface in the process of dry creping tissue paper is disclosed. The adhesive comprises a water-soluble, thermosetting, polyamide-epihalohydrin resin complexed with a metal ion. The adhesive provides controllable adhesion, rewetability, fugitive wet strength and doctorability for dry creping.
Patent AT-E357625-T1 (AT)
Inventor: SEVOLA MAURI
IPC: F16N29/00
Filed: 2001-09-17
Granted: 2007-04-15
Abstract: A lubricant discharge device for discharging lubricant from a bearing housing (1) of an electric motor includes a tubular element (3) consisting of components (3a, 3b) arranged at a lubricant discharge opening (2) in the bearing housing. A piston (4) is arranged inside the tubular element (3) being connected to an arm section (5). The tubular element comprises a first end (3d) placed at the grease discharge opening and a second end (3c) that is opposite to the first end and is situated at the outer edge of an end shield of the electric motor. An opening (6) is provided in the casing of the tubular element close to the second end (3c) of the tubular element, and a closing means (7) is arranged inside the tubular element to open and close the opening (6).
Patent AT-E427318-T1 (AT)
Inventor: LI XIAN
IPC: C12N15/09
Filed: 2001-09-14
Granted: 2009-04-15
Abstract: The present invention is based, in part, on expression studies of IL-2 and IL-15 receptor subunits by cycling T cells  in vivo . In one embodiment, the invention generally features novel combinations of IL-2 and IL-15 antagonists and methods of suppressing the immune response by administering these antagonists. In each case, suppression is achieved by administration of a first agent that targets an IL-15 molecule or an IL-15 receptor (IL-15R) and a second agent that targets an IL-2 molecule or an IL-2 receptor (IL-2R). More generally, the invention features novel combinations of agents that, when administered to a patient (or to a transplant  ex vivo,  reduce the number of antigen-reactive T cells. For example, the invention features compositions (e.g., pharmaceutically acceptable compositions) that include two or more agents, each of which promote T cell death. Alternatively, the composition can contain at least one agent that promotes T cell death and at least one agent that inhibits T cell proliferation. The agent that promotes T cell death can promote AICD (activation induced cell death), passive cell death, ADCC (antibody dependent cell-mediated cytotoxicity) or CDC (complement directed cytotoxicity).
Patent AT-E507585-T1 (AT)
Inventor: AUGUSTO CARLOS J R P
IPC: H01L31/10
Filed: 2001-10-12
Granted: 2011-05-15
Abstract: A method in which thin-film p-i-n heterojunction photodiodes are formed by selective epitaxial growth/deposition on pre-designated active-area regions of standard CMOS devices. The thin-film p-i-n photodiodes are formed on active areas (for example n<SUP>+</SUP>-doped), and these are contacted at the bottom (substrate) side by the "well contact" corresponding to that particular active area. There is no actual potential well since that particular active area has only one type of doping. The top of each photodiode has a separate contact formed thereon. The selective epitaxial growth of the p-i-n photodiodes is modular, in the sense that there is no need to change any of the steps developed for the "pure" CMOS process flow. Since the active region is epitaxially deposited, there is the possibility of forming sharp doping profiles and band-gap engineering during the epitaxial process, thereby optimizing several device parameters for higher performance. This new type of light sensor architecture, monolithically integrated with CMOS, decouples the photo-absorption active region from the MOSFETs, hence the bias applied to the photodiode can be independent from the bias between the source, drain, gate and substrate (well) of the MOSFETs.
Patent AT-E457263-T1 (AT)
Inventor: BLAKLEY ROBERT
IPC: F16C27/02
Filed: 2001-12-28
Granted: 2010-02-15
Abstract: An improved flexible support for a steady bearing in rotational contact with the surface of a shaft allows the bearing and housing to substantially track the contact surface of an impeller shaft when the shaft is subject to elastic deflection during operation. The flexible support employs a flexible disc pack, which is comprised of a plurality of thin, flexible disc elements in a stacked arrangement. The disc pack is mounted to a support ring and is also mounted to the bearing housing such that the bearing housing and other bearing elements are capable of deflection to substantially align with the axis of the impeller shaft when the shaft deflects.
Patent AT-E348792-T1 (AT)
Inventor: WOUDENBERG RICHARD HERMAN
IPC: C07C1/24
Filed: 2001-10-22
Granted: 2007-01-15
Abstract: The present invention relates to a process for preparing 1-indanones of formula (I) and isomers thereof, wherein R<1>, R<2>, R<3>, R<4>, R<5>, and R<6> independently represent H or a C1-C20 hydrocarbon group or R<1> and R<2> or R<2> and R<3> or R<3> and R<4> and/or R<5> and R<6> together with the carbon atoms to which they are attached form a saturated or unsaturated 5- or 6-membered ring, said hydrocarbon group and/or said ring optionally containing one or more hereto atoms, said ring optionally being substituted with a C1-C4 hydrocarbon group, said process comprising reacting a compound of formula (II), wherein R<1>, R<2>, R<3>, R<4>, R<5>, and R<6> have the same meaning as defined above, with a chlorinating agent, followed by reaction with a Friedel-Crafts catalyst. The invention further relates to the preparation of the corresponding indenes.
Patent AT-E340826-T1 (AT)
Inventor: SHARE PAUL E
IPC: B29C49/00
Filed: 2001-10-31
Granted: 2006-10-15
Abstract: The present application relates to a barrier layer consisting of a composition comprising a blend of (i) a polyester resin, (ii) a polyamide material and optionally (iii) an oxygen scavenging material.
Patent AT-E310973-T1 (AT)
Inventor: INAGAKI YASUHIRO
IPC: G02B1/10
Filed: 2002-02-27
Granted: 2005-12-15
Abstract: A dyeing method for dyeing a plastic lens, a plastic lens obtained by use of the dyeing method, and a dyeing system, a dyeing device, and a dyeing jig for a plastic lens are disclosed. The dyeing method includes a producing step of producing a print base body (10) on which a print area (2b) is printed with a sublimatable dye by a printer (40) under control of a computer (50), the printer being previously supplied with the dye; a placing step of placing the print base body and a lens (3) to be dyed so that the print area on the base body is brought into nearly close contact with a lens surface to be dyed; and a transferring step of heating at least the print base body to sublimate the sublimatable dye of the print area, thereby transferring the dye to the lens surface to be dyed. <IMAGE>
Patent AT-E316354-T1 (AT)
Inventor: BURGONI ROBERTO
IPC: A61B1/31
Filed: 2002-07-23
Granted: 2006-02-15
Abstract: A retractor for surgical operations on the arteria haemorrhoidalis comprising a retractor tube (1) having a closed and rounded distal end (101), to be inserted in the anal cavity, a window (8) on the lateral surface, through wich the artery is ligated, and an open proximal end (201) to which is connected a gripping handle (M) which removably houses a light source (F). In the portion (601) connecting the handle to the distal end of the retractor tube a channel is provided housing a parabolic mirror which reflects the light supplied by the light source into the retractor tube to illuminate the lateral window. An ultrasonic probe for the detection of the artery is removably housed in a longitudinal chamber (10) provided at the interior of the retractor tube, extending from the proximal end of the retractor tube to a lateral opening (7). The ultrasonic probe is preferably protected in a thin, disposable and easily removable sterilised sheath to allow the hygienical reutilisation of the same probe. <IMAGE>
Patent AT-E266591-T1 (AT)
Inventor: DE JONG LEEN-PIETER
IPC: B65G57/08
Filed: 2002-09-06
Granted: 2004-05-15
Abstract: A rig for handling empty pallets with a minimum of manual effort has a two side holder (16) comprising a flat base (4) on raised support and with one side (3) at right angles to the base. The holder is held in a support frame which tilts the holder about a horizontal axis. In the transfer position the side is near horizontal, tilting rearwards to enable empty pallets to be easily tipped in and out of the holder. A full holder is simply tilted into the upright position and removed by a fork truck, and vice versa.
Patent AT-E320340-T1 (AT)
Inventor: BREDAHL GUNNAR
IPC: B31F1/07
Filed: 2002-12-03
Granted: 2006-04-15
Abstract: An embossing device for tissue paper converting apparatus, comprises a first roll (12) and a second roll (14) cooperating with each other to emboss a web of tissue paper (30; 30a, 30b) in-between, first protrusions (20) on the circumference of the first roll (12) cooperating with the second roll (14) to form a first nip with a first gap in-between, second protrusions (22; 22a, 22b) on the circumference of the first (12) or second roll (14) cooperating with the other of the first and second roll as a counter roll to form a second nip with a second gap in-between. The embossing device further comprises an adjusting means for selectively adjusting the second gap of the second nip of some or all second protrusions (22; 22a, 22b). <IMAGE>
Patent AT-E340986-T1 (AT)
Inventor: LECUME SERGE
IPC: F42B12/22
Filed: 2002-01-11
Granted: 2006-10-15
Abstract: A fragmentation explosive munition element comprising a casing capable of generating fragments, having an axis of revolution, an explosive charge surrounded by the casing having the same axis of revolution and comprising a hole in the form of a cylindrical canal, the generatrices of which are parallel to the axis of revolution of the charge, a single peripheral and punctual means of initiating the charge. A design of this type makes it possible, for a given explosive charge, to obtain a markedly higher fragment velocity that is obtained with known designs.
Patent AT-E277103-T1 (AT)
Inventor: ROCKS JENS
IPC: C08G59/20
Filed: 2002-01-28
Granted: 2004-10-15
Abstract: A curable casting composition based on epoxide resins shows an unexpectedly high curing rate when the casting composition contains (i) an epoxide group with at least one aminoglycidyl group in the molecule, (ii) a curing agent and (iii) a fluorine containing surfactant (FCS).  A curable casting composition based on epoxide resins shows an unexpectedly high curing rate when the casting composition contains: (i) an epoxide group with at least one aminoglycidyl group in the molecule, (ii) a curing agent and (iii) a fluorine containing surfactant (FCS) of formula (I) in which the hydrophobic residue has the formula (Ia).  R-(C(R)(R1)-C(R)(R1))x-A     (I) R-(C(R)(R1)-C(R)(R1))x-       (Ia) A = the hydrophobic part of the surfactant; R and R1 = H or F; and x = 2-12, preferably 3-5. Independent claims are also included for the following: (1) coatings, adhesives, fiber reinforced plastics, structural parts and electrical insulation obtained from the composition; (2) a process for preparation of the composition by mixing the components and additives in any order, preferably by premixing component (iii) with components (i) or (ii) to give the finished composition.
Patent AT-E297346-T1 (AT)
Inventor: HANNEN REINER
IPC: B65B9/13
Filed: 2002-02-21
Granted: 2005-06-15
Abstract: An apparatus for wrapping an object having vertical sides and a top with a hood-shaped foil having a closed end and an open end fits the foil over the object in such a manner that excess-foil projections are formed at the closed end that project outward from the top of the object and an empty space is formed adjacent each projection between the foil and the object. The excess-foil projections are mechanically engaged and physically tucked between the object and the foil to push the projections into the respective empty spaces.
Patent AT-E350591-T1 (AT)
Inventor: PERROT PHILIPPE
IPC: B62D25/18
Filed: 2002-02-13
Granted: 2007-01-15
Abstract: The invention relates to a holding device for fixing a car body element to the structure of a motor vehicle. The inventive device is of the type that comprises a panel (10) formed by a sheet (11) which defines a support face that is adapted to co-operate with the car body clement and,which comprises means (14, 15) for locking to the car body clement and frangible means (16) for releasing the car body element. Said device also comprises an element (30) for quarter-turn fixing in an opening in the structure which is used to hold the assembly formed by the panel (10) and the car body element.
Patent AT-E337432-T1 (AT)
Inventor: AEMMAELAE ARI
IPC: D21D5/02
Filed: 2002-03-08
Granted: 2006-09-15
Abstract: The invention relates to a method of controlling quality of pulp. Pulp formed in mechanical defibering of wood is screened into at least two fractions, the accept that has passed the screening phase being forwarded for further use and the reject that did not pass the screening being removed from the screening phase. The invention comprises determining flow amount and consistency of the pulp supplied to the screening phase and, correspondingly, of the reject removed therefrom, and calculating a passage ratio of the reject and the supplied pulp by means of the flow amounts and consistency values verified through the measurement, and adjusting the screening phase according to said passage ratio.
Patent AT-E321051-T1 (AT)
Inventor: KRANTIS ANTHONY
IPC: C07D311/74
Filed: 2002-01-11
Granted: 2006-04-15
Abstract: Multi-ring organic compounds useful in compositions and methods for regulating gut motility to modulate food intake and treat obesity and malnutrition are described.
Patent AT-E537612-T1 (AT)
Inventor: RICK ROLAND
IPC: H04B7/06
Filed: 2002-01-11
Granted: 2011-12-15
Abstract: In an antenna diversity environment, the timing offset of the receiver's fingers are based on the timing offset of the received peaks of the base station transmit signals. In a system with non-negligible multipath spacing, the timing offset of the received peaks of the base station transmit signals are not necessarily at the same location. In one embodiment, the demodulating elements for the signal from each base station antenna use the same offset for demodulating and determining an error signal based on pilot signal sampling prior to the timing offset and subsequent to the timing offset. The error signals are averaged and used by a time tracking loop to track the incoming signal. In another embodiment, the demodulating elements for the signal from each base station antenna independently time track the signals with different timing offsets for each finger. The preferred embodiment depends on the method used by the base station to multiplex the data onto multiple transmit antennas.
Patent AT-E367810-T1 (AT)
Inventor: KRAMMER STEPHANIE
IPC: A61K9/12
Filed: 2002-03-11
Granted: 2007-08-15
Abstract: Galenical formulations of a mixture comprising the following components : 
(a) at least one isoflavone, one isoflavone glycoside, or a mixture thereof; 
(e) at least one polyunsaturated fatty acid, and optionally 
(f) a vitamin which is selected from the group consisting of vitamin D, derivatives of vitamin D, vitamin K, derivatives of vitamin K, and mixtures thereof and/or 
(g) adjuvants and excipients in quantities as required, preferably within the range of 0.1 to 20% by weight, based on the total weight of the mixture  
and their use for preventing osteoporosis and stiumulating oesteogenesis in mammals.
Patent AT-E516596-T1 (AT)
Inventor: METZLER RICHARD
IPC: H01L29/866
Filed: 2002-05-08
Granted: 2011-07-15
Abstract: Semiconductor diodes having a low forward conduction voltage drop, a low reverse leakage current, a high voltage capability and avalanche energy capability, suitable for use in integrated circuits as well as for discrete devices are disclosed. The semiconductor diodes are diode configured vertical metal oxide semiconductor field effect devices formed using cylindrical semiconductor pedestals (304) on a surface of a semiconductor body and having one diode terminal (324) as the common connection between the gates (318) and drains (312) of the vertical metal oxide semiconductor field effect devices, and one diode terminal (330) as the common connection with the sources (314) of the vertical metal oxide semiconductor field effect devices. A layer (320) of opposite conductivity type to that of the semiconductor body is disposed below said surface of the semiconductor body between pedestals.
Patent AT-E332917-T1 (AT)
Inventor: NAICKER SELVARAJ
IPC: A61K38/00
Filed: 2002-10-17
Granted: 2006-08-15
Abstract: The invention is directed to isomeric mixtures of cyclosporine analogues that are structurally similar to cyclosporine A. The mixtures possess enhanced efficacy and reduced toxicity over the individual isomers and over naturally occurring and other presently known cyclosporines and cyclosporine derivatives. Embodiments of the present invention are directed toward cis and trans-isomers of cyclosporin A analogs referred to as ISA Tx 247, and derivatives thereof. Mixtures of ISA Tx 247 isomers exhibit a combination of enhanced potency and reduced toxicity over the naturally occurring and presently known cyclosporins. ISA Tx 247 isomers and alkylated, arylated, and deuterated derivatives are synthesized by stereoselective pathways where the particular conditions of a reaction determine the degree of stereoselectivity. Stereoselective pathways may utilize a Wittig reaction, or an organometallic reagent comprising inorganic elements such as boron, silicon, titanium, and lithium. The ratio of isomers in a mixture may range from about 10 to 90 percent by weight of the (E)-isomer to about 90 to 10 percent by weight of the (Z)-isomer, based on the total weight of the mixture.